EFFICACY, SAFETY, AND QOL IN MM-003, A PHASE3, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY OF POMALIDOMIDE (POM) plus LOW-DOSE DEXAMETHASONE (LODEX) VS HIGH-DOSE DEXAMETHASONE (HIDEX) IN RRMM